IGC PHARMA, INC. Shares Repurchased and Retired
IGC PHARMA, INC. (IGC) had Shares Repurchased and Retired of 80.00 thousand shares as of 2019-03-23, per its 10-K filed 2019-06-14.
Discontinued › Shareholders' Equity
us-gaap:StockRepurchasedAndRetiredDuringPeriodShares · last filed 2019-06-14
- 2019-03-23: Stock Repurchased and Retired During Period, Shares 80.00K shares.
| Period end | Stock Repurchased and Retired During Period, Shares |
|---|---|
| 2019-03-23 | 80.00K shares 10-K · filed 2019-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |